"Farewell to the cursed year 2020, the arrival of 2021 and the good news at the beginning of the year, India got the first corona vaccine".
The cursed 2020 is gone and the new year 2021 has arrived. And at the beginning of this new year, there was great good news, India got the first corona vaccine.
The coronavirus vaccine 'Covishield' from the University of Oxford has been cleared by the expert committee of the Central Drugs Standards Control Organization for emergency use.
However, they said in the news that it has not been finalized yet, only from the center. However, the expert committee is still meeting on this issue.
They said the ‘Covishield’ vaccine would be officially cleared by the Drug Controller General of India very soon. Generally, the Drug Controller General of India gives emergency clearance only on the recommendation of an expert committee.
But it is unknown at this time what he will do after leaving the post. However, the Union Ministry of Health said that the final decision on vaccine clearance would be taken by the Drug Controller General of India (DCGI).
It is learned that a meeting of the expert committees is underway and at the end of the meeting, the expert committee will make recommendations to the DCGI.
It is learned that Oxford has developed this 'Covishield' vaccine in collaboration with the British-Swedish drug manufacturer Astra Zeneca. The vaccine produced in India by the Seram Institute of India.
Indian companies have entered into an agreement to create a dose of about 100 crore corona tickers for low- and middle-income people in the country.
The meeting was chaired by members of the DCGI for the second time and was supposed to review two more vaccines, Pfizer-Enbiotic and Bharat Biotech, in addition to the ‘Covishield’ vaccine, but one of the delegates declined to comment.
The Oxford vaccine has been approved by the ‘MHRA’ in Britain on an emergency basis, and they say the vaccine should be given in two doses to people aged 18 and over every 4-12 weeks.